N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES
This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta 11 N-terminal site, i.e. A 11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
11.11.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to antibodies, including specified portions or variants, specific for at least the human Amyloid-beta 11 N-terminal site, i.e. A 11-x peptides. It further provides methods of making and using said antibodies, including therapeutic formulations, administration and devices. |
---|---|
Bibliography: | Application Number: EP20030798156 |